HomeAI · summaries
Storia in 2 fonti
Remepy raises $36 million to expand AI-enabled drug pipeline
The Hybrid Drug company says the funding will support Phase III development of its Parkinson’s treatment Hybridopa, expand pharma partnerships and advance its platform combining prescription drugs with AI-driven therapeutic apps
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of…
Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's Disease
- ·
ynetnews.com
Remepy raises $36 million to expand AI-enabled drug pipeline
The Hybrid Drug company says the funding will support Phase III development of its Parkinson’s treatment Hybridopa, expand pharma partnerships and advance its platform combining…